CA
NZ
UK
AU
IND
US
David A. Cherechinsky, President and CEO of DNOW Inc., filed a Form 4 on August 12, 2026, reporting the exercise of two tranches of non-qualified stock options and the same-day sale of the resulting common shares on August 10, 2026.
Raymond W. Chang, VP and General Counsel of DNOW Inc., filed a Form 4 on August 12, 2026, disclosing the exercise of two non-qualified stock option grants and same-day sales of the resulting common shares on August 10, 2026.
Director Elsy Lisa Boglioli of FTI Consulting, Inc. filed a Form 4 on August 12, 2026, disclosing the sale of 900 shares of common stock on August 11, 2026, to satisfy tax obligations arising from a prior equity award vesting.
A Form 4 filed with the SEC on August 12, 2026, discloses that Joseph F. Grimaldo, a director of Avidia Bancorp, Inc. (NASDAQ:AVBC), purchased 4,655 shares of common stock on August 11, 2026.
A Form 4 filed with the SEC on August 12, 2026, reports that Kennedy O Saul, a director of Avidia Bancorp, Inc. (NASDAQ:AVBC), purchased a total of 5,900 shares of common stock across six transactions on August 11, 2026.
Thomas B. Okray, a director of Monro, Inc. (NASDAQ:MNRO), filed a Form 4 on August 12, 2026, reporting the acquisition of 11,149 shares of common stock through a restricted stock award granted on August 11, 2026.
A Form 4 filed with the SEC on August 12, 2026 discloses that Nick L. Stanage, a director of AMETEK INC/ (NYSE:AME), purchased 4,000 shares of the company's common stock on August 11, 2026.
Nelson Griggs, President of Capital Access Platforms at Nasdaq, Inc. (NASDAQ:NDAQ), filed a Form 4 on August 12, 2026, disclosing the sale of 3,226 shares of common stock on August 10, 2026.
A Form 4 filed on August 12, 2026 with the SEC discloses that Jeremy Skule, Executive Vice President and Chief Strategy Officer of Nasdaq, Inc. (NASDAQ:NDAQ), sold 2,250 shares of common stock on August 10, 2026 pursuant to a Rule 10b5-1(c) trading plan.
A Form 4 filed with the SEC on August 12, 2026, discloses that Albert Bourla, Chairman and CEO of Pfizer Inc, purchased 38,000 shares of Pfizer common stock on August 12, 2026.
Please wait processing your request...